Ophthalmogenetics and Gene Therapy

Ophthalmic hereditary qualities are worried about the hereditary commitment to ophthalmic illness, including assurance of examples and dangers of legacy, and in addition finding, visualization, and advancement of medications for hereditary variations from the norm. The advances in gene therapy maintain extensive promise for the cure of ophthalmic conditions. Gene therapy is additionally in a position to deal with primary open-angle glaucoma (POAG) in animal models, and research show it is economically viable. Genes may additionally be delivered into cells in vitro or in vivo making use of viral or non-viral vectors. Recent technical advances have led to the demonstration of the molecular basis of a range of ocular diseases.

  • Genetics of Myopia Development
  • Gene Therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy
  • Genetics of Myopia Development

Related Conference of Ophthalmogenetics and Gene Therapy

November 14 - 15, 2019

33rd European Ophthalmology Congress

Madrid, Spain

Venue: Rafael Hoteles forum Alcala
November 14-15, 2019

20th Global Ophthalmologists Annual Meeting

Amsterdam, Netherlands
November 19-20, 2019

Global Opthalmologists Annual Meeting

Johannesberg, South Africa
December 05-06, 2019

3rd World Congress on Eye and Vision

Abu Dhabi, UAE
December 09-10, 2019

World Eye and Vision Congress

Dubai, UAE
February 19-20 2020

4th International Conference on Ophthalmology

Osaka, Japan
March 02-03, 2020

5thGlobal Pediatric Ophthalmology Congress

Rome, Italy
April 13-14, 2020

World Congress on Ophthalmology & Optometry

London, UK
October 19-20, 2020

19th Asia Pacific Ophthalmologists Annual Meeting

| Singapore

Ophthalmogenetics and Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in